Mitiglinide Description

Mitiglinide is a biologic for the analysis of blazon 2 diabetes .Mitiglinide is anticipation to activate insulin beard by closing the ATP-sensitive K(+) (K(ATP)) channels in pancreatic beta-cells.

Mitiglinide belongs to the meglitinide chic of claret glucose-lowering drugs. It is accustomed for use in Japan but has not yet acquired FDA approval.

Mitiglinide is anticipation to activate insulin beard by bounden to and blocking ATP-sensitive K(+) (K(ATP)) channels (Kir6.2/SUR1 complex, KATP channels) in pancreatic beta-cells. Closure of potassium channels causes depolarization which stimulates calcium arrival through voltage-gated calcium channels. High intracellular calcium after triggers the exocytosis of insulin granules.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s